Craig Sauter

Dr. Sauter is an Assistant Attending and the Clinical Director of the Adult BMT Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSKCC). His research has focused on improving the outcome of patients with relapsed and refractory (rel/ref) non-Hodgkin lymphoma (NHL) with hematopoietic cell transplantation (HCT) and cellular therapy. He has reported on successive phase II studies for allogeneic HCT in NHL patients. He has also investigated prognostic factors based upon imaging, both functional and computed tomography, that have predicted outcomes in these studies. He has been a principal and co-principal investigator of prospective clinical studies of chimeric antigen receptor (CAR) T cells against CD19 in B cell malignancies. He is currently introducing novel therapeutics, both pharmacologic and cellular, into salvage and HCT platforms of both autologous and allogeneic graft sources for rel/ref NHL patients.